logo
In Uganda, a tougher bicycle offers hope for better health coverage in rural areas

In Uganda, a tougher bicycle offers hope for better health coverage in rural areas

LIRA, Uganda (AP) — The bicycle parked in Lucy Abalo's compound doesn't belong to her. Any one of the hundreds of people in her village can show up and ask to use it.
A man might wish to take his pregnant wife for a checkup. A woman might need transport to pick up HIV medication. An injured child might need a trip to a hospital.
'The goodness about this bike,' Abalo said, is its availability to all.
She is one of dozens of 'village doctors' in rural Uganda who recently were supplied with the Buffalo Bicycle, so called because its steel parts are reinforced to perform in areas with bad roads.
World Bicycle Relief, a Chicago-based nonprofit, promotes the Buffalo Bicycle in remote parts of Africa. It collaborates with governments, non-governmental groups and others who use the bikes to improve access to health services.
In Uganda, an east African country of 45 million people, efforts to market the bicycle have focused on supporting health workers like Abalo, who visits people's homes and reports any issues to authorities.
As a community health extension worker, or CHEW, she has gained the trust of villagers, who can knock on her door in emergency situations. She said she helps to look after about 8,000 people in the area.
And at least twice a week, she is required to report to a government-run health center about 5 kilometers (3 miles) away and assist with triaging patients.
Ugandan health authorities acknowledge that one challenge for CHEWs is transportation, part of a larger burden of poverty that can leave health facilities lacking ambulances or even gas to move them.
World Bicycle Relief, operating locally as Buffalo Bicycles Uganda, has collaborated with Ugandan health authorities since 2023 to equip 331 CHEWs in two of the country's 146 districts. One is Lira, 442 kilometers (274 miles) north of the capital, Kampala.
Bicycles have long been ubiquitous, and many families tend to have one. Cultural norms in northern Uganda don't prohibit women from riding. While the roads in Lira town are paved, dirt paths lead into the heart of the district where farming is the main economic activity.
The Buffalo Bicycle is a recent arrival. Many have never heard of it, or can't afford it. Retailing for roughly $200, it is three times more expensive than the cheapest regular bicycle — otherwise out of reach for many CHEWs, who do not yet earn a salary.
The bike's promoters cite its durability in rough terrain, needing fewer trips to the mechanic as a way to save money.
The Buffalo Bicycle's heavy-gauge steel frame is so strong that it comes with a five-year warranty, said Amuza Ali, a monitoring officer in Lira for Buffalo Bicycles Uganda.
Abalo and others told the AP the Buffalo Bicycle felt uncomfortable to use in the beginning, with a braking system that doesn't permit carefree backpedaling.
'When I climbed on it, it wasn't that easy as I thought,' Abalo said. 'I was like, 'I am trying again to learn how to ride.''
CHEWs using the bicycles reported a 108% increase in households reached each week, and the time to reach health facilities dropped by nearly half, according to a study published in May by World Bicycle Relief.
The study shows that 'mobility is not a luxury in healthcare' but a lifeline, CEO Dave Neiswander said in a statement released for the report.
Diana Atwine, permanent secretary at the Ministry of Health, has urged the distribution of bicycles to more CHEWs across Uganda, saying front-line health workers save an unknown number of lives each year.
Abalo received her Buffalo Bicycle from the health minister last year.
One of her neighbors, Babra Akello, said she has used the bicycle at least six times already. The first was for transport to an antenatal checkup. She praised Abalo's willingness to help.
The bike has also been used for emergencies. One evening earlier this year, a neighbor's 4-year-old child suffered a deep cut while playing in the dirt. With the child's parents away, Abalo transported the bleeding boy to a facility where he briefly lost consciousness before being revived.
'That bike, not me, saved the life of that child,' Abalo said. 'If that bike hadn't been there, I don't know what would have happened.'
___

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health Insurers Take Major Accountability Step On Prior Authorization
Health Insurers Take Major Accountability Step On Prior Authorization

Forbes

timean hour ago

  • Forbes

Health Insurers Take Major Accountability Step On Prior Authorization

The nation's biggest health insurance companies are poised to ease prior authorization, the process ... More of insurers reviewing hospital admissions and medications. Details of the changes will be announced as early as Monday, June 23, 2025. getty The nation's biggest health insurance companies are poised to ease prior authorization, the process of insurers reviewing hospital admissions and medications. The policy change, expected to be announced as early as Monday by America's Health Insurance Plans, also known as AHIP, and the Chicago-based Blue Cross Blue Shield Association has been at the forefront of legislative efforts in Washington and state capitals across the country. The health insurers effort to improve accountability, transparency and customer support after an outpouring of public anger at the health insurance industry following the Dec. 4 UnitedHealthcare CEO shooting. Doctors complain prior authorization has delayed needed treatment and put patient health in jeopardy while wasting physician time to jump through hoops and adding to physician burnout. Over the past several years, prior authorization increasingly has become a concern for patient access to needed services, according to almost 30% of physicians responding to an American Medical Association survey in 2023. Health insurers involved in the effort say companies have agreed to streamline, simplify and reduce prior authorization, according to two health plans with knowledge of the changes. Neither AHIP nor the Blue Cross Blue Shield Association would comment when reached Friday afternoon. AHIP represents some of the biggest names in health insurance including CVS Health's Aetna, Centene, Cigna, Humana and Elevance Health. Blue Cross Blue Shield Association represents the nation's Blue Cross plans including Florida Blue and Health Care Service Corp., parent of Blue Cross and Blue Shield plans in five states. Sources close to the effort from participating plans say the insurers are committed to the changes in all health plans that they sell including commercial coverage, Medicare Advantage for seniors and Medicaid health plans that they administer for low-income Americans via contracts with states. The changes could benefit more than 250 million Americans. Further details weren't available. The effort is the latest and biggest so far among health insurers. Earlier this year, The Cigna Group announced a new multi-year effort to improve accountability. Cigna's announcement to launch 'actions to drive positive change for customers and patients' came just days after company chief executive David Cordani addressed analysts and investors on the industry's need to provide customers with more support and resources to navigate the healthcare system. 'In early December, we all witnessed the tragic murder of Brian Thompson, a leader at the UnitedHealth Group,' Cordani told analysts and investors on the company's fourth quarter and full year 2024 earnings call. 'The past several weeks have further challenged us to even more intensely listen to the public narrative about our industry. At The Cigna Group, we are further accelerating improvements in innovations to increase transparency, expand support and drive even greater accountability." Cigna was the first rival of UnitedHealth Group's UnitedHealthcare to roll out some reforms since the shooting in New York on the company's annual investor day. Thompson's death unleashed a barrage of scrutiny on health insurer denials of medical care and certain other business practices from social media trolls and industry critics including some in Congress who say they'd like to see reform.

The American Diabetes Association Demonstrates Its Commitment to Curbing the Obesity Epidemic with Obesity Standards of Care
The American Diabetes Association Demonstrates Its Commitment to Curbing the Obesity Epidemic with Obesity Standards of Care

Yahoo

time2 hours ago

  • Yahoo

The American Diabetes Association Demonstrates Its Commitment to Curbing the Obesity Epidemic with Obesity Standards of Care

Symposium previews new content for Standards of Care in Overweight and Obesity, designed to improve patient care and outcomes CHICAGO, June 20, 2025 /PRNewswire/ -- Recent developments for the new Standards of Care in Overweight and Obesity guidelines, the first clinical guidance of its kind, were presented during the Standards of Care in Overweight and Obesity 2025 Updates symposium at the 85th Scientific Sessions of the American Diabetes Association® (ADA) in Chicago. The Obesity Association™, a division of the ADA, recently announced the publication of Weight Stigma and Bias: Standards of Care in Overweight and Obesity—2025, along with the Introduction & Methodology section in BMJ Open Diabetes Research & Care. This comes at a time when about 110 million American adults are impacted by obesity. Further, up to (53%) of new cases of type 2 diabetes are attributed to obesity every year, demonstrating the need for comprehensive, evidence-based guidelines to inform care. The symposium highlighted key insights on physician guidelines for weight stigma and bias, including training for health care professionals, creating inclusive clinical environments, person-centered communication, shared decision making, and evidence-based interventions. Additionally, researchers highlighted what is next for the clinical guidelines, including a potential section for pharmacologic treatment and a preview of what is going to be covered in that section. The Standards of Care in Overweight and Obesity 2025 Updates symposium is one of many obesity-related symposia and abstracts at the 85th Scientific Sessions, spanning basic through clinical and implementation science. Additional studies highlighting groundbreaking developments obesity treatment and care to be presented at ADA's annual meeting include: Once-Monthly MariTide for the Treatment of Obesity in People with or without Type 2 Diabetes—A 52-Week Phase 2 Study ADJUnct Semaglutide Treatment in Type 1 Diabetes (ADJUST-T1D) Trial Outcomes Can We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass? The BELIEVE Study of Bimagrumab + Semaglutide PATHWEIGH Trial—Building the Highway for Weight Management in Primary Care First Report of a Phase 3 RCT of Orforglipron, a Small Nonpeptide GLP-1RA, as Monotherapy in Drug-Naïve Type 2 Diabetes with Inadequate Glycemic Control—The ACHIEVE-1 Trial Efficacy and Safety of CagriSema 2.4mg/2.4mg in Adults with Overweight/Obesity—The REDEFINE 1 and REDEFINE 2 Clinical Trials "The ADA's Standards of Care in Diabetes guideline is the gold standard for diabetes care and management," said Raveendhara Bannuru, MD, PhD, the ADA's vice president, medical affairs and lead author of the guidelines. "The new Standards of Care in Overweight and Obesity guidelines stand to yield significant impact and progress in patient care, and it's only just the beginning." As part of the ADA's ongoing commitment to combating obesity, new clinical practice guidelines and initiatives are continually being developed to advance the quality of care. Research presentation details:Dr. Bannuru and other Professional Practice Committee members will present these findings at the symposium: Standards of Care in Overweight and Obesity 2025 Updates Friday, June 20 from 12:45–1:45 p.m. About the ADA's Scientific SessionsThe ADA's 85th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Chicago, IL, on June 20–23. Thousands of leading physicians, scientists, and health care professionals from around the world are expected to convene both in person and virtually to unveil cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. Attendees will receive exclusive access to thousands of original research presentations and take part in provocative and engaging exchanges with leading diabetes experts. Join the Scientific Sessions conversation on social media using #ADASciSessions. About the Obesity Association Obesity is an epidemic that demands both attention and action. The Obesity Association, a division of the American Diabetes Association, is dedicated to reducing the prevalence of obesity and improving health outcomes. Through a focus on education, action, and evidence-based support, we strive to create a world where people affected by obesity can thrive. About the American Diabetes AssociationThe American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure—and we're not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn). Media Contact: Mimi Carmody, MCarmody@ View original content to download multimedia: SOURCE American Diabetes Association Sign in to access your portfolio

L-Nutra Health Unveils Real-World Diabetes Remission Outcomes at ADA, Spotlighting Success of Nutrition-Driven Lifestyle Medicine
L-Nutra Health Unveils Real-World Diabetes Remission Outcomes at ADA, Spotlighting Success of Nutrition-Driven Lifestyle Medicine

Yahoo

time2 hours ago

  • Yahoo

L-Nutra Health Unveils Real-World Diabetes Remission Outcomes at ADA, Spotlighting Success of Nutrition-Driven Lifestyle Medicine

Results highlight A1C improvements, reduced reliance on medications, and strong patient engagement through personalized, root-cause-based care CHICAGO, June 20, 2025 /PRNewswire/ -- L-Nutra Health, the medical division of nutrition technology leader L-Nutra, presented compelling real-world data today at the American Diabetes Association's 85th Scientific Sessions, reinforcing the success of lifestyle medicine in reversing the course of type 2 diabetes. The data reflects the outcomes of a comprehensive, clinically guided nutrition and lifestyle program that supports the management and potential reversal of metabolic disease and type 2 diabetes at their root—addressing insulin resistance, visceral fat, and cellular aging. The outcomes, drawn from 125 individuals enrolled in L-Nutra Health's Diabetes Remission and Regression Program (DRRP), demonstrated improvements in glycemic control, reductions in diabetes medication use, and meaningful weight loss—without relying on pharmaceutical or lifestyle intensification. "This is a powerful demonstration of what happens when you replace reactive care with proactive, personalized nutrition therapy," said Dr. Joseph Antoun, MD, CEO and Chairman of L-Nutra. "Instead of managing symptoms, we're helping patients resolve the underlying dysfunction driving their disease." Key outcomes presented: The mean age of the study volunteers was 61.7 years, with body mass index of 31.8, diabetes duration of 10.7 years and baseline HbA1c of 7.6%. 54% of participants reduced diabetes medications at 3 months; 68% at 6 months HbA1c decreased by 0.5 % at 3 months and maintained at 6 months Average weight loss of 4.0 kg at 3 months and 5.1 kg at 6 months Diabetes Treatment Satisfaction Score (DTSQ) improved from 26.9 at baseline to 30.4 at 6 months The abstract was presented by Ashley Bizzell RD, LDN, CDCES, Director of Clinical Nutrition and Global Training at L-Nutra Health, who leads the clinical nutrition team delivering the intervention. "These findings are truly encouraging—pairing the fasting-mimicking diet with personalized guidance and support from a dietitian presents a compelling approach to driving remission in type 2 diabetes," said Bizzell. "As a dietitian, it reinforces the critical role that nutrition-centered care can play in reversing chronic disease and restoring metabolic health." "The Fasting Mimicking Diet (FMD) is a patented, nutrition-based therapeutic that delivers the cellular and metabolic benefits of fasting—without full food deprivation," said Dr. William Hsu, MD, Chief Medical Officer of L-Nutra and former VP at Harvard's Joslin Diabetes Center. "When integrated with physician oversight and registered dietitian support, it enables clinically significant metabolic improvements with less dependence on costly medications and minimal lifestyle disruption—an outcome rarely achieved in standard care." An Innovative Model Based on Personalized, Root-Cause CareThe L-Nutra Health program integrates evidence-based nutrition protocols—including a patented, low-glycemic dietary intervention that mimics the effects of fasting—with bi-monthly Registered Dietitian coaching, medical oversight by a team of board-certified lifestyle medicine physicians, laboratory review, and medication reduction as appropriate. Patients receive individualized care plans that aim to drive disease remission and regression, optimize weight care, improve insulin sensitivity and biological age score —shifting the treatment paradigm from glucose control to true metabolic restoration. Backed by over 25 years of research, including funding from the NIH and clinical partnerships with 34 global institutions, this model offers a cost-effective, sustainable, and scalable alternative to pharmaceutical-first diabetes care. To learn more about L-Nutra Health's Diabetes Remission & Regression Program, visit About L-Nutra HealthL-Nutra Health is transforming how metabolic disease is treated—through lifestyle medicine-based therapeutic programs that address root causes, drive towards disease remission, and reduce medication reliance. Founded on the scientific discoveries of Dr. Valter Longo and backed by over $36 million in NIH funding, L-Nutra Health integrates nutri-technology , digital tools, and expert care to create structured, personalized programs for diabetes, obesity, insulin resistance, hypertension and more. View original content to download multimedia: SOURCE L-Nutra Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store